Patent · US Active

Anticoagulation fluid comprising citrate and phosphate

US10420797B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

GAMBRO LUNDIA AB · SE

Inventors

Jan Sternby · Lund, SE
Anders Wieslander · Lund, SE

Key dates

Filing date	Apr 30, 2014
Grant date	Sep 24, 2019
Priority date	—
Expiry date	Apr 30, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concerns an anticoagulation fluid comprising 10-40 mM citrate and 0.1-4 mM phosphate. The anticoagulation fluid is to be used for regional citrate anticoagulation in an extracorporeal blood circuit. The anticoagulation fluid may be combined with at least one treatment fluid in the dialysis treatment, and it may be included in a system for regional citrate anticoagulation in an extracorporeal blood circuit.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.